Filter announcements
Loading...
Camlin Fine Sciences is engaged in the Business of Speciality Chemicals.
CAMLINFINE clarified an "inadvertent discrepancy" in its Standalone Financial Results (Total Income) between PDF and XBRL filings for the quarter and year ended March 31, 2025. The company confirmed this error has been corrected, with revised integrated results filed. This ensures previously disclosed figures are now accurate.
Camlin Fine Sciences has released its unaudited financial results for the quarter and nine months ended December 31, 2024. For the standalone segment, total income reached ₹20,507.1 lakh, with a net loss of ₹1,426.9 lakh, compared to a loss of ₹719.5 lakh in the previous quarter. The consolidated revenue was...